Depression and associated physical diseases and symptoms by Goodwin, Guy M.
epression is sometimes described as the “com-
mon cold”of psychiatry.It is certainly common,and it is
also present most commonly in mild forms, which
extends the analogy somewhat. However, in its most
severe forms it is the major problem that may preoccupy
any ill patient—to the point where he or she may com-
mit suicide.Indeed,a formal major depressive episode
can occur in association with virtually all the other psy-
chiatric and physical diagnoses.This review will address
primarily physical illnesses.
Physical illness increases the risk of developing severe
depressive illness.There are two broadly different mech-
anisms that may explain this, which are not mutually
exclusive.The first is the most obvious,probably the most
common,and is usually described as having a psycholog-
ical or cognitive mechanism.It may be understandable as
the threat that any severe and/or chronic illness may pose
to an individual’s sense of purpose and meaning in life.
Thus,the illness may provide the life event or chronic dif-
ficulty that triggers a depressive episode in a vulnerable
individual.Physical illness may thereby be a component
of the complex pathway that determines the emergence
of depression.The mechanisms may be both genetic and
nongenetic,and have been best teased out by twin stud-
ies,primarily in women.
1-3 Such an association between
depression and physical illness may be highly nonspecific
and unbiological. However, this cannot be assumed
axiomatically to be true.Indeed,all severe depression is
in some sense biological,and some unexpected associa-
tions may be mediated by a biology that is related to both
the physical illness and to the systems that support
depressive reactions.Examples of the more specific asso-
ciation will be given below; they may turn out to be of
particular etiological interest.
In addition, major depression, but especially minor
depression,dysthymia,and depressive symptoms merge
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Depression can occur in association with virtually all the
other psychiatric and physical diagnoses. Physical illness
increases the risk of developing severe depressive illness.
There are two broadly different mechanisms. The most
obvious has a psychological or cognitive mechanism. Thus,
the illness may provide the life event or chronic difficulty
that triggers a depressive episode in a vulnerable individ-
ual. Secondly, more specific associations appear to exist
between depression and particular physical disorders.
These may turn out to be of particular etiological interest.
The best examples are probably stroke and cardiovascu-
lar disease. Finally, major depression, but especially minor
depression, dysthymia, and depressive symptoms merge
with other manifestations of human distress with which
patients present to their doctors. Such somatic presenta-
tions test the conventional distinction between physical
and mental disorder, and are a perennial source of con-
troversy.      
© 2006, LLS SAS Dialogues Clin Neurosci. 2006;8:259-265.with other manifestations of human distress,with which
patients present to their doctors.Such somatic presenta-
tions test the conventional distinction between physical
and mental disorder,and are a perennial source of con-
troversy.While it will not be possible to do the topic full
justice,the key issues will be noticed.
Depressive illness and stroke
After severe stroke,it has been suggested that depression
is more common and,more critically,that the particular
site of the brain insult may influence the risk of subse-
quent mood disorder.Thus,a nonspecific risk from the
problems posed by disability may be compounded by a
more specific neuropsychiatric impact,depending on the
localization of the lesion.The obvious problem is that
both the disability and the putative direct impact on
depression neurobiology might be expected to vary with
the localization,and inevitably confound one explanation
with the other.
The original stroke studies recruited patients requiring
hospital admission and longer-term care.They suggested
an association between depression and the left frontal
pole regions,and euphoria and right hemisphere lesions.
4
In fact such stroke events may be unrepresentative of
cerebrovascular events in general;confirmation in more
representative cases with less severe disability would
have been interesting.In fact,the story remains a little
confused. In an unselected series of patients recruited
from the community,in the 12 months after stroke,“emo-
tionalism”occurred in 10% to 20% and was associated
with left-sided anterior lesions
5 but there were few cases
of major depression.However,subsequently,the same
study was written up much more negatively.
6A compa-
rably negative study has been reported using a similar
sample of stroke patients.
7The rates of depression vary
between series
8 and are likely to be influenced by a range
of general risk factors for depression. These might be
expected to often swamp the effects of the site of lesion.
9
Certainly, it would be misleading to suggest that there
exists a particularly consistent relationship between most
strokes and depression.
Nevertheless,in an appropriate case–control series,there
could be associations between lesion location and risk of
depression that would be of neurobiological interest.For
example, lesions in the region of the left basal ganglia
have been suggested to be more specifically associated
with depression.
10 Larger community studies of cardio-
vascular disease (not stroke per se) have also suggested
an association between depressive symptoms and lesions
of the basal ganglia.
11
Whatever the etiology,depression is of appreciable prac-
tical importance for the management of stroke patients
who develop it.
12 Depressive symptoms shortly after
stroke (not major depression itself) predict increased
mortality in unselected stroke patients.
13 Pharmacological
treatment of post-stroke depression has been subjected
to a number of small controlled trials.The evidence is
that antidepressants are effective, although some tri-
cyclics may be prone to produce confusion,so selective
serotonin reuptake inhibitors (SSRIs) or other less toxic
medicines are probably preferable.
14
Heart disease
Findings in patients with myocardial infarction (MI) who
show depressive symptoms have also proved interesting.
There appears to be an association between short-term
mortality following MI and the presence of significant
depressive symptoms in the acute-care setting.For exam-
ple,in 222 patients interviewed between 5 and 15 days fol-
lowing the MI and followed up for 6 months,depression
was a significant and independent predictor of mortality
from cardiac causes (95% confidence interval [CI],4.61 to
6.87).
15The effect was confirmed at 18 months.
16 Indeed,it
is sometimes claimed that a depression questionnaire is
more informative than an intracardiac electrocardiogram
(ECG)! Depressive symptoms are also associated with
increased medical comorbidity post-MI,which is a further
mechanism likely contributing to a poor outcome.
17The
depressive syndrome following MI has not been suffi-
ciently characterized,but one small study has suggested
atypical features.
18
Traditionally,it might be supposed that depressive symp-
toms after MI would be reactive and psychological in ori-
gin.It would be easy enough to construct the usual plau-
sible story. In fact, there is evolving evidence that
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Selected abbreviations and acronyms
CBT cognitive behavioral therapy
CFS chronic fatigue syndrome
FM fibromyalgia
IBS irritable bowel syndrome
MCS multiple chemical sensitivity
MI myocardial infarct
SSRI selective serotonin reuptake inhibitordepressive symptoms can predict an elevated risk of MI
many years before it occurs
19 and/or in the few weeks
before an acute admission
20A follow-up of the Baltimore
cohort of the Epidemiologic Catchment Area (ECA)
study showed that,compared with respondents with no
history of dysphoria,the odds ratio for MI associated with
a history of dysphoria was 2.07 (95% confidence interval
[CI],1.16 to 3.71),and with a history of major depressive
episode was 4.54 (95% CI,1.65 to 12.44),independent of
coronary risk factors.
21A recurrence detected in the coro-
nary care unit may carry a particularly poor prognosis.
22
Patients with severe affective disorder have been known
to have an increased mortality from cardiovascular
causes for a long time (eg,ref 23,24) and the nature of
the association between the two is of considerable evolv-
ing interest.The most common cause of death is proba-
bly cardiac arrhythmia.
16 It may be relevant that
depressed patients with stable heart disease have higher
resting heart rates and lower variability during ordinary
activity.
25 Autonomic dysfunction may be the cause of
subsequent fatal arrhythmia.Thus,it is possible,as with
stroke,that some patients show an association between
heart disease and depression that is biological in origin.
The control of autonomic function may colocalize with
limbic representations of stress,anxiety,and mood.If so
the complex temporal associations between MI events
and depression could originate from common central
representations.Unfortunately for the generality of this
idea,recent findings in stable patients with ischemic heart
disease showed no relationship between depression and
heart rate variability indices.
26
If patients with heart disease are depressed,how should
they be treated? One influential idea has been that sero-
tonin may provide the common factor between MI and
depression.The logic is a little tortuous since MI is puta-
tively associated with increased platelet function under the
influence of serotonin,and depression with reduced sero-
tonin function centrally.However,SSRIs might simulta-
neously increase central nervous system (CNS) seroton-
ergic function while depleting the platelet of serotonin.
27
The SADHEART study compared the SSRI sertraline
with placebo in patients with recent MI or unstable angina.
It showed reduced depressive symptoms after sertraline,
especially in more depressed patients.However,cardio-
vascular benefits were not discriminable,although the trial
was underpowered to detect worthwhile differences in
rates of severe events.
28 SSRIs are usually regarded as first
line,primarily on safety grounds.Clearly,the fact of recent
myocardial infarction is a reason for cautious prescribing,
but the field rests primarily on precautionary principles
rather than a wealth of trial data.
29
A psychological intervention might appear more logical
than drug treatment on safety grounds alone,but expe-
rience has been mixed:effects in one study of behavior
therapy were positive for hostility but negative for
depression
30—a potentially undesirable outcome.In the
longer term,it has proved difficult to show an effect of
treatment for depression on cardiac outcomes.
31
Depression in association with 
nonspecific somatic complaints; chronic pain, 
fibromyalgia, and chronic fatigue
Depressive symptoms,and depressive syndromes,are seen
more commonly in association with a variety of conditions
that often have physical or somatic presentations.There
are a range of these disorders with much in common,both
with each other and with low-level depression. They
include a variety of chronic pain states,fibromyalgia,and
chronic fatigue.One could also add,although they will not
be much addressed here,irritable bowel syndrome,multi-
ple chemical sensitivity,and some of the “syndromes”asso-
ciated with army service (eg,“Gulf War syndrome”).
The common factor is usually chronic pain or discomfort,
and,one may add,a general uncertainty about the etiology.
It hard to know whether separate symptoms or syndromes
represent cause or effect.Indeed,the different medical tra-
ditions converging on these patients frequently take oddly
polarized views about the causality,and even whether such
patients are really ill.It is the kind of disagreement also
much beloved of the popular press.Such medical confu-
sion is inevitably likely to confound the sentiments of
patients who are themselves uncertain whether they are
really ill,or consciously or unconsciously have something
to gain from the sick role.It would be impossible to do full
justice to the debate that rages around a diagnosis such as
chronic fatigue or Gulf War syndrome in a short chapter
on depression.Instead,it may be more useful to notice how
depression may be related to the more obvious symptoms
that characterize the various syndromes.
Minor depression,dysthymia,and depressive personality
The problem starts with minor depression.Minor depres-
sive states have long presented a diagnostic confusion.
Efforts to wring meaningful classifications out of minor
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more obvious temperamental abnormality or with more
prominent anxiety or somatic symptoms,remain of dubi-
ous clinical value.The Diagnostic and Statistical Manual of
Mental Disorders,4th edition (DSM-IV) includes a cate-
gory of mood disorder described as dysthymia,where a
few depressive symptoms are present for over 2 years.As
well as those symptoms contributing to a diagnosis of
major depression,there are features such as pessimism,
low self-esteem,low energy,irritability,and decreased pro-
ductivity.These clinical cases would previously have been
subsumed under the notion of neurasthenia or depressive
personality
32 but their credibility has been increased by the
reports of responsiveness to pharmacological treatment.
33,34
Medicines of greater specificity and lower side-effect pro-
file than tricyclic antidepressants and old-style monoamine
oxidase inhibitors (MAOIs) have made treatment feasi-
ble.The diagnosis can also be made in patients with super-
imposed major depression.
What of depressive personality disorder? Personality dis-
order is defined to be present from adolescence and
invariant,more or less,throughout life.Akiskal has argued
that temperament is critical to understanding the spectrum
of chronic affective disorder,
35 so echoing an earlier gen-
eration of clinicians who saw illnesses as reactions by per-
sonality types.
36 Measures of personality such as neuroti-
cism are stable across the adult lifespan
37 and predict
vulnerability to depression.
3 Personality dimensions seem
to require continua not categories,and the diagnosis of dis-
crete syndromes would in general be enriched by system-
atic measures of personality or other dispositions.
Minor states can only really be understood in relation to
population norms from appropriate large-scale represen-
tative studies.There appears to be a more or less continu-
ous distribution between the well and the ill with regard
to a range of measures of subjective distress, particular
symptoms or groups of symptoms,duration,and degree of
impairment.Where one sets the threshold for the defini-
tion of “a case of depression”therefore determines what
actual percentage value one obtains for incidence and
prevalence.As we will see below,minor syndromes over-
lap with other complaints with a more physical emphasis.
Chronic pain
Chronic pain syndromes may be focal or diffuse.The best
known focal pain syndromes are probably pelvic pain
and temporomandibular joint pain.The best known dif-
fuse pain syndrome is “fibromyalgia”(now the term pre-
ferred to the earlier fibrositis): fibromyalgia is chronic
widespread pain and tenderness (the latter manifested as
multiple tender points).Physical investigations tend to
be negative.Increased rates of psychiatric disorders,par-
ticularly depressive,anxiety,and somatoform disorders,
are apparent in clinic and community populations.
Depression may be associated with the onset and persis-
tence of fibromyalgia symptoms. Seen from one per-
spective,fibromyalgia is sometimes seen as the somatic
expression of psychological distress—somatization.
Although this is as much a restatement of the problem as
a convincing solution to it. Furthermore, deriving as it
does from Freud’s formulation of conversion syndromes,
it carries the pejorative implication that such symptoms
are hysterical (see ref 38 for an extreme statement of that
view).An alternative view accepts that somatic symp-
toms are simply part of the depressive syndrome,perhaps
magnified as an individual difference in some subgroups.
This would predict a necessary overlap with depression,
and a potentially shared etiology.The evidence for this
might proceed from heritability,biology,and treatment
similarities.The pattern within families indeed suggests
that fibromyalgia is a depressive spectrum disorder.
39
Other similarities with the depressive phenotype include
cognitive impairments
40 and disorders of the hypothal-
amo-pituitary axis.
41 Finally,the symptoms of fibromyal-
gia are responsive to antidepressants.
42
Chronic fatigue 
Chronic fatigue syndrome (CFS) has proved to be an
even more controversial diagnosis. The complaint of
fatigue is common in community surveys, as indeed is
that of low spirits or mild depression. The number of
somatization symptoms and history of a dysphoric
episode are the two strongest predictors of new onset of
fatigue as well as recurrent/chronic fatigue over a 13-year
follow-up interval in the Epidemiological Catchment
Area (ECA) study.A history of unexplained fatigue at
baseline was also a very high risk for new-onset major
depression compared with those who never reported
such fatigue,(RR = 28.4;95% CI,11.7,68.0).
43
The etiology of chronic fatigue is complex and heteroge-
neous.Data for “interfering fatigue”(IF) has been obtained
on 7740 individual twins giving a prevalence of 9.9% in the
previous year.IF was significantly associated with 42 of 52
potential correlates! There were two broad clusters:
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neuroticism;
• Beliefs of ill health coexisting with alcoholism and
stressful life events.
Genetic effects may be particularly important in women,
and shared environmental effects in men.
44
Clinic samples show a similarly heterogeneous picture.
In women,chronic fatigue syndrome,fibromyalgia (FM),
and multiple chemical sensitivity (MCS) show mutual
comorbidity:of 163 women with CFS,37% also met cri-
teria for FM, and 33% met criteria for MCS. Patients
with additional illness were more likely to have major
depression and a higher risk of psychiatric morbidity
compared with patients in the CFS only group.
45 This
offers support for the notion of a single syndrome,per-
haps with weakly distinct dimensions. Indeed, a larger
statistical analysis of 646 patients who met accepted cri-
teria for CFS and/or FM,suggested four latent classes dif-
fering in a graded fashion (rather than qualitatively) for
symptom endorsements,premorbid characteristics,and
comorbidity with panic disorder and major depression.
CFS and FM appear to have more common points than
they do differences.
46
The relationship between major depression and severe
chronic fatigue can be investigated biologically.Fatigue
is of course a common symptom of depression.The find-
ings from investigation of neuropsychological function
echo the pattern of broad similarities and some poten-
tially defining differences: depressed patients showed
marked diurnal variation in motor function and more
severe memory impairment.
47 Patients with chronic
fatigue syndrome also show a specific sensitivity to the
effects of exertion on effortful cognitive functioning,not
seen in major depression.This occurs despite subjective
and objective evidence of effort allocation in chronic
fatigue syndrome.It suggests that patients have reduced
working memory capacity,or a greater demand to mon-
itor cognitive processes,or both.
48
Comorbidity is also seen with irritable bowel syndrome
(IBS).A systematic review of all the comorbidity studies
of IBS
49 showed that the disorders with the best-docu-
mented association were fibromyalgia (median of 49%
have IBS), chronic fatigue syndrome (51%), temporo-
mandibular joint disorder (64%),and chronic pelvic pain
(50%).Major depression,anxiety,and other psychiatric
disorders occurred in up to 94% of IBS cases.
The treatment of these conditions is as controversial as
their diagnosis has often been.There are advocates of
antidepressants,graded exercise,and cognitive behavior
therapy (CBT).In some cases it is confusing.Thus,in one
trial, CBT was shown to be superior to a more simple
intervention.
50 In another,it was comparable to counsel-
ing.
51The evidence supporting all the available interven-
tions remains limited
52 and the cost of providing them
potentially quite high. Antidepressants are probably
widely prescribed,although their value in primary care
remains uncertain.
Conclusion
The challenge of the mood disorders lies in their appar-
ently rising incidence and prevalence,the realization that
long-term disability and even mortality is likely to be
increasingly evident,and the need for better delivery of
more effective treatments.Their association with other
disorders may provide clues to etiology,especially relat-
ing to brain mechanisms underlying reward and
stress/autonomic regulation. The greatest uncertainty
relates to their co-occurrence with somatic syndromes
which are common and poorly understood.There is a risk
that the ubiquitous use of the term depression is becom-
ing potentially counterproductive.There is a danger that,
just as the authenticity of cases of functional disturbance
or somatization is frequently doubted, so depression
diagnoses now come to be seen as little more than
endorsements of minor distress.This may do a disservice
not only to those individuals whose minor syndromes are
major to them,but also those patients with more severe
depression whose treatment may be difficult and whose
suffering may be discounted. ❏
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La depresión y síntomas y enfermedades
físicas asociadas
La depresión puede asociarse con virtualmente
todos los otros diagnósticos físicos y psiquiátricos.
La enfermedad física aumenta el riesgo de desa-
rrollar una enfermedad depresiva grave. En térmi-
nos generales existen dos mecanismos diferentes.
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ducirse en una dificultad crónica que gatilla un
episodio depresivo en un individuo vulnerable. En
segundo lugar, parecen existir asociaciones más
específicas entre la depresión y ciertos trastornos
físicos. Estas pueden resultar de especial interés
etiológico. Los mejores ejemplos son probable-
mente el accidente vascular cerebral y la enferme-
dad cardiovascular. Finalmente, la depresión mayor,
pero especialmente la depresión menor, la distimia
y los síntomas depresivos aparecen junto con otras
manifestaciones del distrés humano con el cual los
pacientes se presentan a sus médicos. Dichas pre-
sentaciones somáticas prueban la distinción con-
vencional entre trastorno físico y mental, y consti-
tuyen una fuente perenne de controversia. 
Dépression, symptômes et troubles 
physiques associés
En pratique, la dépression peut être concomitante
de tous les autres troubles physiques et psychia-
triques. Les troubles physiques augmentent le
risque de développer une dépression sévère. Il
existe deux sortes de mécanismes généralement dif-
férents. Le plus évident est un mécanisme psycho-
logique ou cognitif. La maladie peut donc être à
l’origine de l’événement de vie ou d’une difficulté
chronique qui déclenche un épisode dépressif chez
un individu vulnérable. Des associations plus spé-
cifiques semblent exister secondairement entre la
dépression et les troubles physiques particuliers.
Ceci peut s’avérer d’un intérêt étiologique spéci-
fique. Les accidents vasculaires cérébraux et la mala-
die cardiovasculaire en sont probablement le
meilleur exemple. Finalement, la dépression
majeure mais surtout la dépression mineure, la dys-
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